Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
QMRO Home
William Harvey Research Institute
Centre for Biochemical Pharmacology
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
QMRO Home
William Harvey Research Institute
Centre for Biochemical Pharmacology
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Volume
60
DOI
10.1183/13993003.congress-2022.3305
ISSN
0903-1936
Metadata
Show full item record
Authors
Burkill, S; Porsbjerg, CM; Bourdin, A; Tran, TN; Martin, N; Katial, R; Barker, P; Wechsler, ME; Maspero, J; Bosnic-Anticevich, S
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/84829
Collections
Centre for Biochemical Pharmacology
[332]